Aili He

Platelet factor 4–induced T _H 1-T _reg polarization suppresses antitumor immunity

Androgens and erythropoiesis: Past and present

Targeted Approaches to Inhibit Sialylation of Multiple Myeloma in the Bone Marrow Microenvironment

Homoharringtonine and omacetaxine for myeloid hematological malignancies

Circular RNA Splicing

Biology and Clinical Observations of Regulatory T Cells in Cancer Immunology

Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy

Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point

Hidradenitis suppurativa

The biogenesis, biology and characterization of circular RNAs

CXCR3 ligands in disease and therapy

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells

Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application

Circles reshaping the RNA world: from waste to treasure

Successful treatment of primary refractory anemia with a combination regimen of all-trans retinoic acid, calcitriol, and androgen

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia

[Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma].

Silencing Long Non-Coding RNA ST3GAL6-AS1 Inhibits Adhesion and Migration of Myeloma Cells in Vitro

[Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism].